CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Call for Feedback: Optimal Pharmacotherapy for Transplant-Ineligible Multiple Myeloma

Published on: November 22, 2019
Result type: News

A new project on Optimal Pharmacotherapy for Transplant-Ineligible Multiple Myeloma is now available for feedback from all interested stakeholders.

Optimal Pharmacotherapy for Transplant-Ineligible Multiple Myeloma

Call for Feedback: 2019-11-22
Feedback Due By: 2019-12-06
Consultation Document: Proposed Project Scope
Product Type: Therapeutic Review

Submit Feedback